1Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL
2The Retina Group of Washington, Silver Spring, MD
3Associated Retinal Consultants, Royal Oak, MI
Corresponding Author: R.V. Paul Chan, MD, MBA, MSc, Address: 1855 West Taylor Street, Suite 3.138, Chicago, IL 60612, Phone: (312) 996-6590, Fax: (312) 996-7770, Email: [email protected]
The authors have no proprietary interest.
The cases presented in this report were evaluated at the Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL.
Disclosures: R. V. Paul Chan is a consultant for Phoenix Technology (Pleasanton, CA), Novartis (South San Francisco, CA) and Alcon (Ft. Worth, TX). None of these disclosures are relevant to the content of this report.
Funding Sources: Support by grants P30EY10572, P30EY001792, and R01EY029673 from the National Institutes of Health (Bethesda, MD) and unrestricted departmental funding from Research to Prevent Blindness (New York, NY). The content is solely the responsibility of the authors and does not necessarily represent the official views of these organizations.
